Astellas Pharma Inc
F:YPHA

Watchlist Manager
Astellas Pharma Inc Logo
Astellas Pharma Inc
F:YPHA
Watchlist
Price: 11.1 EUR
Market Cap: 19.9B EUR

Relative Value

The Relative Value of one YPHA stock under the Base Case scenario is hidden EUR. Compared to the current market price of 11.1 EUR, Astellas Pharma Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

YPHA Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
57
vs Industry
62
Median 3Y
1.7
Median 5Y
2.2
Industry
2.7
Forward
1.8
vs History
50
vs Industry
1
Median 3Y
38.1
Median 5Y
30.1
Industry
21.5
Forward
18.6
vs History
90
vs Industry
27
Median 3Y
13.8
Median 5Y
13.2
Industry
16.7
vs History
23
vs Industry
20
Median 3Y
19
Median 5Y
22.1
Industry
23
vs History
19
vs Industry
42
Median 3Y
2
Median 5Y
2.2
Industry
2.3
vs History
65
vs Industry
57
Median 3Y
1.8
Median 5Y
2.1
Industry
2.9
Forward
1.9
vs History
65
vs Industry
71
Median 3Y
2.2
Median 5Y
2.6
Industry
5.6
vs History
49
vs Industry
22
Median 3Y
11
Median 5Y
11.1
Industry
13.2
Forward
7.9
vs History
12
vs Industry
2
Median 3Y
19.9
Median 5Y
17.4
Industry
16.6
Forward
8.5
vs History
87
vs Industry
24
Median 3Y
14.7
Median 5Y
12.3
Industry
15.8
vs History
92
vs Industry
16
Median 3Y
23.5
Median 5Y
17.2
Industry
19
vs History
55
vs Industry
58
Median 3Y
1.1
Median 5Y
1.5
Industry
2

Multiples Across Competitors

YPHA Competitors Multiples
Astellas Pharma Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Astellas Pharma Inc
F:YPHA
3.7T EUR 1.9 30 11.1 25.9
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.2 55.6 37.2 39.9
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
497.5B USD 5.4 19.8 16.2 21
CH
Roche Holding AG
SIX:ROG
261.4B CHF 4.2 27.7 11.8 13.8
UK
AstraZeneca PLC
LSE:AZN
213.8B GBP 5 30.6 108.3 158.4
CH
Novartis AG
SIX:NOVN
210.3B CHF 4.7 18.5 11.7 15.1
US
Merck & Co Inc
NYSE:MRK
263B USD 4.1 13.8 9.8 11.6
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.6 13.9 9.7 11.3
IE
Endo International PLC
LSE:0Y5F
212.8B USD 91.8 -72.8 337 845
US
Pfizer Inc
NYSE:PFE
142B USD 2.3 14.5 7.4 10.1
P/E Multiple
Earnings Growth PEG
JP
Astellas Pharma Inc
F:YPHA
Average P/E: 24.9
30
71%
0.4
US
Eli Lilly and Co
NYSE:LLY
55.6
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.8
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.7
29%
1
UK
AstraZeneca PLC
LSE:AZN
30.6
37%
0.8
CH
Novartis AG
SIX:NOVN
18.5
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13.8
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.9
3%
4.6
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -72.8 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.5
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
JP
Astellas Pharma Inc
F:YPHA
Average EV/EBITDA: 400.6
11.1
5%
2.2
US
Eli Lilly and Co
NYSE:LLY
37.2
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.2
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.8
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.3
10%
10.8
CH
Novartis AG
SIX:NOVN
11.7
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.8
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.7
1%
9.7
IE
E
Endo International PLC
LSE:0Y5F
337
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
JP
Astellas Pharma Inc
F:YPHA
Average EV/EBIT: 1 714
25.9
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.9
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.8
6%
2.3
UK
AstraZeneca PLC
LSE:AZN
158.4
23%
6.9
CH
Novartis AG
SIX:NOVN
15.1
12%
1.3
US
Merck & Co Inc
NYSE:MRK
11.6
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
11.3
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
845
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.1
7%
1.4